Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-008076
Filing Date
2021-06-30
Accepted
2021-06-30 14:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28881
2 filename2.txt TEXT-EXTRACT 3447
  Complete submission text file 0000000000-21-008076.txt   43820
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Filed for) CIK: 0001786255 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)